Description:

GYNECOLOGIC ONCOLOGY GROUP Treatment Completion Form - FORM Q0 NCT00565851 Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA632D3C-41EC-2430-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA632D3C-41EC-2430-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/8/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

GYNECOLOGIC ONCOLOGY GROUP Treatment Completion Form - FORM Q0 NCT00565851

No Instruction available.

  1. StudyEvent: GYNECOLOGIC ONCOLOGY GROUP Treatment Completion Form - FORM Q0
    1. No Instruction available.
Header module
Treatment Schedule
Off-treatment Reason
Reason treatment ended (check only one)
Will patient receive further treatment?
Comments

Similar models